Literature DB >> 17080278

Sacral nerve stimulation in fecal incontinence: are there factors associated with success?

Guillaume Gourcerol1, Syrine Gallas, Francis Michot, Philippe Denis, Anne-Marie Leroi.   

Abstract

PURPOSE: Sacral nerve stimulation has been used successfully in treating fecal incontinence. This study was designed to evaluate the proportion of patients with unsuccessful implantation despite positive test stimulation and to examine and compare factors associated with the success of the transitory and permanent sacral nerve stimulation.
METHODS: A total of 61 patients (55 females; median age, 56 (range, 33-77) years) with refractory fecal incontinence underwent temporary stimulation. A 50 percent or greater improvement in the number of episodes of fecal incontinence or urgency was required to proceed to permanent implantation and was the criteria of success of permanent sacral nerve stimulation at the last follow-up visit in implanted patients. The factors compared between the success and the failure groups during temporary and permanent stimulation were patients' age and gender, diagnosis and characteristics of fecal incontinence, previous surgery, quality of life scores, anorectal manometry, endoanal ultrasound, and electrophysiologic tests performed before stimulation.
RESULTS: Temporary stimulation was successful in 35 patients (57.4 percent). A permanent neurostimulation device was implanted in 33 patients. Age was the only factor related to success of the temporary stimulation (P=0.03). After permanent implantation, 31 percent of patients did not attain screening phase results for the number of episodes of fecal incontinence or urgency. A neurologic disorder was more frequently the origin of fecal incontinence in the success group compared with others (P=0.03). The left bulbocavernosus reflex was more frequently delayed in the success group than in the others (P=0.03), and a prolonged or absent bulbocavernosus reflex was more frequent in the success group than in the failure group (P=0.03).
CONCLUSIONS: Patients with fecal incontinence from neurologic origins could be good candidates for sacral nerve stimulation.

Entities:  

Mesh:

Year:  2007        PMID: 17080278     DOI: 10.1007/s10350-006-0746-4

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

1.  Defecation: Sacral nerve stimulation therapy for defecatory disorders.

Authors:  Klaus E Matzel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07       Impact factor: 46.802

2.  Sacral nerve stimulation in the treatment of severe faecal incontinence: long-term clinical, manometric and quality of life results.

Authors:  P Moya; A Arroyo; J Lacueva; F Candela; L Soriano-Irigaray; A López; M A Gómez; I Galindo; R Calpena
Journal:  Tech Coloproctol       Date:  2013-04-27       Impact factor: 3.781

Review 3.  Current status: new technologies for the treatment of patients with fecal incontinence.

Authors:  Andreas M Kaiser; Guy R Orangio; Massarat Zutshi; Suraj Alva; Tracy L Hull; Peter W Marcello; David A Margolin; Janice F Rafferty; W Donald Buie; Steven D Wexner
Journal:  Surg Endosc       Date:  2014-03-08       Impact factor: 4.584

4.  Long-term outcome after overlapping anterior anal sphincter repair for fecal incontinence.

Authors:  Gery Lamblin; Paule Bouvier; Henri Damon; Philippe Chabert; Stephanie Moret; Gautier Chene; Georges Mellier
Journal:  Int J Colorectal Dis       Date:  2014-09-04       Impact factor: 2.571

5.  Sacral neuromodulation for faecal incontinence: is the outcome compromised in patients with high-grade internal rectal prolapse?

Authors:  Siriluck Prapasrivorakul; Martijn P Gosselink; Martijn Gosselink; Kim J Gorissen; Simona Fourie; Roel Hompes; Oliver M Jones; Chris Cunningham; Ian Lindsey
Journal:  Int J Colorectal Dis       Date:  2014-11-30       Impact factor: 2.571

6.  Efficacy and quality of life 2 years after treatment for faecal incontinence with injectable bulking agents.

Authors:  J Danielson; U Karlbom; T Wester; W Graf
Journal:  Tech Coloproctol       Date:  2012-12-07       Impact factor: 3.781

7.  Sacral nerve stimulation for fecal incontinence improves symptoms, quality of life and patients' satisfaction: results of a monocentric series of 119 patients.

Authors:  Henri Damon; Xavier Barth; Sabine Roman; François Mion
Journal:  Int J Colorectal Dis       Date:  2012-08-12       Impact factor: 2.571

8.  Baseline factors predictive of patient satisfaction with sacral neuromodulation for idiopathic fecal incontinence.

Authors:  Jakob Duelund-Jakobsen; Bart van Wunnik; Steen Buntzen; Lilli Lundby; Søren Laurberg; Cor Baeten
Journal:  Int J Colorectal Dis       Date:  2014-04-18       Impact factor: 2.571

9.  Sacral neuromodulation for the treatment of fecal incontinence and urinary incontinence in female patients: long-term follow-up.

Authors:  Galal El-Gazzaz; Massarat Zutshi; Levilester Salcedo; Jeff Hammel; Raymond Rackley; Tracy Hull
Journal:  Int J Colorectal Dis       Date:  2009-06-02       Impact factor: 2.571

Review 10.  Evidence-Based Update on Treatments of Fecal Incontinence in Women.

Authors:  Isuzu Meyer; Holly E Richter
Journal:  Obstet Gynecol Clin North Am       Date:  2016-03       Impact factor: 2.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.